Phreesia and Livongo Health have filed a registration statement on Form S-1 with the SEC relating to a proposed initial public offering (IPO) of shares of their common stocks. The number of shares to be offered by either of the two companies and the price range for the proposed offerings have not yet been determined. Phreesia intends to list its common stock on the New York Stock Exchange under the ticker symbol “PHR,” while Livongo has applied to list its common stock on the Nasdaq Global Select Market under the ticker symbol “LVGO.”
J.P. Morgan, Wells Fargo Securities and William Blair are acting as joint book-running managers for Phreesia’s proposed offering as representatives of the underwriters. Allen & Company LLC and Piper Jaffray are acting as passive book-running managers for the proposed offering.
Meanwhile, Livongo is working with Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, and J.P. Morgan Securities LLC which will serve as lead joint book-running managers for the proposed offering. Piper Jaffray & Co. and SVB Leerink LLC will serve as lead co-managers and Canaccord Genuity LLC, KeyBanc Capital Markets Inc. and Needham & Company, LLC will serve as co-managers for the proposed offering.
The proposed offerings will be made only by means of a prospectus.
Phreesia’s SaaS platform aims to engage patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care.
On the other hand, Livongo’s platform empowers people with chronic conditions to live better and healthier lives, beginning with diabetes and now including hypertension, weight management, diabetes prevention, and behavioral health.
UPDATE: Previously the article only covered Phreesia’s IPO. It was updated to include Livongo’s proposed offering as well.